Search Results 721-730 of 15985 for melatonin receptor agonists

  1. Peripheral Neural Mechanisms of Exercise Intolerance in Heart Failure - Mayo Clinic

    About this study. The goal of this project is to study mechano- and- metaboreceptor function (mechanoreflex and metaboreflex, respectively) associated with ...

  2. Pulmonary and Critical Care Medicine Fellowship (Minnesota)

    Mayo Clinic School of Graduate Medical Education offers a two- or three-year Pulmonary and Critical Care Medicine Fellowship in Rochester, Minnesota.

  3. Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  4. A Study to Evaluate the Effectiveness and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. Methylnaltrexone (subcutaneous route) - Mayo Clinic

    Methylnaltrexone injection is used to treat constipation caused by opioids (narcotic pain medicines), in adults with long-lasting pain that is not caused by ...

  6. Clinical trials - Brain Tumor Program

    Memantine hydrochloride may enhance cognitive function by binding to and inhibiting channels of receptors located in the central nervous system. Radiation ...

  7. Network Neuro-modulation for Mesial Temporal Lobe Epilepsy - Mayo Clinic

    The purpose of this study is to demonstrate the safety and feasibility of chronic mesial temporal lobe epilepsy (MTLE) network recordings with 4 implanted depth ...

  8. Telmisartan and hydrochlorothiazide (oral route) - Mayo Clinic

    A lower blood pressure can reduce the risk of strokes and heart attacks. Telmisartan is an angiotensin II receptor blocker (ARB). It works by blocking a ...

  9. Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma - Mayo Clinic

    Patients with ALK aberrant tumors (ALK tyrosine kinase mutation or ALK amplification) will be non-randomly assigned to receive crizotinib added to current COG ...

  10. Growth Hormone for the Treatment of Gastroparesis - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...